Drug Type Small molecule drug |
Synonyms MLN 120B, PS 1145 |
Target |
Mechanism IKKβ inhibitors(inhibitor of nuclear factor kappa B kinase subunit beta inhibitors), NF-kappa-B-repressing factor inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H11ClN4O |
InChIKeyJZRMBDHPALEPDM-UHFFFAOYSA-N |
CAS Registry431898-65-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | US | - | |
Multiple Sclerosis | Preclinical | US | - | |
Neoplasms | Preclinical | US | - | |
Pulmonary Disease, Chronic Obstructive | Preclinical | US | - | |
Rheumatoid Arthritis | Preclinical | US | - |